Detalhe da pesquisa
1.
Cyclin D1 expression in breast cancer patients receiving adjuvant tamoxifen-based therapy.
Clin Cancer Res
; 14(6): 1767-74, 2008 Mar 15.
Artigo
Inglês
| MEDLINE | ID: mdl-18347178
2.
Inosine 5'-monophosphate dehydrogenase inhibition by mycophenolic acid impairs maturation and function of dendritic cells.
Clin Chim Acta
; 364(1-2): 139-47, 2006 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-16051207
3.
Young age as an independent adverse prognostic factor in premenopausal patients with breast cancer.
Clin Breast Cancer
; 3(1): 65-72, 2002 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-12020397
4.
Low p27 expression predicts early relapse and death in postmenopausal hormone receptor-positive breast cancer patients receiving adjuvant tamoxifen therapy.
Clin Cancer Res
; 15(18): 5888-94, 2009 Sep 15.
Artigo
Inglês
| MEDLINE | ID: mdl-19723645
5.
Zoledronic acid prevents cancer treatment-induced bone loss in premenopausal women receiving adjuvant endocrine therapy for hormone-responsive breast cancer: a report from the Austrian Breast and Colorectal Cancer Study Group.
J Clin Oncol
; 25(7): 820-8, 2007 Mar 01.
Artigo
Inglês
| MEDLINE | ID: mdl-17159195
6.
Induction of permeability across endothelial cell monolayers by tumor necrosis factor (TNF) occurs via a tissue factor-dependent mechanism: relationship between the procoagulant and permeability effects of TNF.
Blood
; 100(4): 1334-9, 2002 Aug 15.
Artigo
Inglês
| MEDLINE | ID: mdl-12149215
7.
Combined analysis of two phase II trials in patients with primary and advanced breast cancer with epidoxorubicin and docetaxel+granulocyte colony stimulating factor.
Anticancer Drugs
; 13(1): 67-74, 2002 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-11914643